Link Fund Solutions Ltd
CIK
1792424
Location
LONDON, X0
Portfolio Value
Small
$111,779,927
Diversification
Highly concentrated
Filing Date
Mar 31, 2020
Global Rank
#2,978
/ 5,303
· as of Mar 2020
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-2.7%
Period ended 6 years ago
Filed Apr 16, 2020 · 6y
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+66.6%
SPY
+76.5%
Annualised alpha
-2.3%
Max drawdown
−34.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
1 positions · as of Mar 31, 2020Top Position
100.0%
of portfolio value
Top 5
100.0%
of portfolio value
Top 10
100.0%
of portfolio value
HHI
10,000
Highly concentrated
Sector Breakdown
As of Mar 31, 2020| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $111,779,927 |
1 positions ·
$111,779,927 total
· as of Mar 31, 2020
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TBPH |
Theravance Biopharma, Inc.
Healthcare
|
First | 4,836,864 | $111,779,927 | 100.00% |